Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07520591Not Yet Recruiting

Valvosoft Outcomes Registry for Real-World Evidence

Role: lead

NCT06650839Not ApplicableWithdrawn

POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy

Role: lead

NCT03779620Not ApplicableCompleted

Valvosoft First-In-Man Study in Severe Symptomatic Aortic Stenosis

Role: lead

NCT05235568Not ApplicableCompleted

VALVOSOFT® Pivotal Study

Role: lead

NCT04665596Not ApplicableCompleted

Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis

Role: lead

NCT03371524Completed

A Prospective RegistrY of Cardiac Echographic Loops

Role: lead

All 6 trials loaded